割り当てるリスクと相対リスクの報告, 1966-97年

Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.

Biochemical and biophysical research communications·1992

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Journal of medicinal chemistry·1992

Sequential change of heterogeneous cerebral blood blow patterns after diffuse brain ischemia.

Resuscitation·1992

[Pulmonary arteriography and bronchial arteriography in pulmonary embolism].

Nihon Kyobu Shikkan Gakkai zasshi·1992

Low copper and brain abnormalities in fetus from triethylene tetramine dihydrochloride-treated pregnant mouse.

Journal of nutritional science and vitaminology·1992

Forestomach neoplasm induction in F344/DuCrj rats and B6C3F1 mice exposed to sesamol.

Japanese journal of cancer research : Gann·1992

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece.

Therapeutic innovation & regulatory science·2026

[Violation of Prohibitions and Restrictions When Importing Footwear Products into the EAEU as a Threat to the Health and Safety of Consumers].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026

Human Rights as Justifications in Wildernesses: A Third World Approach to EU Law.

Jus cogens·2026

A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction.

Human reproduction (Oxford, England)·2026

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

Journal of clinical medicine·2026

Rapid Analysis of Glyphosate, Glufosinate and N-Acetyl Glufosinate in Sesame by Liquid Chromatography-Tandem Mass Spectrometry.

Foods (Basel, Switzerland)·2026

関連する実験動画

割り当てるリスクと相対リスクの報告, 1966-97年

関連する概念動画

Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Sequential change of heterogeneous cerebral blood blow patterns after diffuse brain ischemia.

[Pulmonary arteriography and bronchial arteriography in pulmonary embolism].

Low copper and brain abnormalities in fetus from triethylene tetramine dihydrochloride-treated pregnant mouse.

Forestomach neoplasm induction in F344/DuCrj rats and B6C3F1 mice exposed to sesamol.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece.

[Violation of Prohibitions and Restrictions When Importing Footwear Products into the EAEU as a Threat to the Health and Safety of Consumers].

Human Rights as Justifications in Wildernesses: A Third World Approach to EU Law.

A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction.

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

Rapid Analysis of Glyphosate, Glufosinate and N-Acetyl Glufosinate in Sesame by Liquid Chromatography-Tandem Mass Spectrometry.

関連する実験動画

割り当てるリスクと相対リスクの報告, 1966-97年

関連する概念動画

関連記事